// App-Quantinova.ai

: Advanced Risk Stratification in Multiple Myeloma Beyond Traditional FISH: The First Prospective Real-World Evidence for SKY92 Gene Expression Profiling

Researchers

Presenter

  • Xiang Zhou

Principal Investigators

  • Cornelia Vogt

  • Silvia Nerreter

  • Eva Teufel

  • Emilia Stanojkovska

  • Marietta Truger

  • Benedict Engel

  • Anastasia Barcic

  • Jessica Peter

  • Christine Riedhammer

  • Max Johannes Steinhardt

  • Xianghui Xiao

  • Hannah Hornburger

  • Seungbin Han

  • Larissa Haertle

  • Umair Munawar

  • Julia Mersi

  • Claudia Haferlach

  • Hermann Einsele

  • Leo Rasche

  • K. Martin Kortuem

Medical Centers

  • Department of Internal Medicine II, University Hospital Wuerzburg, WüRzburg, Germany

  • HO-CNIO Hematological Malignancies Group, Clinical Research Unit. CNIO, Madrid, Spain

  • Universitaetsklinikum Wuerzburg, Med. Klinik und Poliklinik II, Wuerzburg, Germany

  • University Hospital Würzburg, Würzburg, Germany

  • Mildred Scheel Early Career Center (MSNZ), University Hospital Würzburg, Würzburg, DEU

  • MLL Munich Leukemia Laboratory, Inning am Ammersee, Germany

Locations

  • Germany

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Syndecan-1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Prospective

  • Global

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved